Thoracic Cancer (Aug 2022)

Relationship between consolidation tumor ratio and tumor‐infiltrating lymphocytes in small‐sized lung adenocarcinoma

  • Yuki Ono,
  • Tetsuzo Tagawa,
  • Fumihiko Kinoshita,
  • Naoki Haratake,
  • Kazuki Takada,
  • Mikihiro Kohno,
  • Tomoyoshi Takenaka,
  • Takeshi Kamitani,
  • Mototsugu Shimokawa,
  • Yoshinao Oda,
  • Masaki Mori,
  • Tomoharu Yoshizumi

DOI
https://doi.org/10.1111/1759-7714.14524
Journal volume & issue
Vol. 13, no. 15
pp. 2134 – 2141

Abstract

Read online

Abstract Background Consolidation tumor ratio (CTR) is associated with cancer progression and histological invasiveness in lung adenocarcinoma (LAD). However, little is known about the association between CTR and immune‐related factors, including tumor‐infiltrating lymphocytes (TILs) density or tumor expression of programmed death ligand 1 (PD‐L1) and indoleamine 2,3‐dioxygenase 1 (IDO1) in small‐sized LAD. Methods This study included 258 patients with LAD (<3 cm) who underwent surgery. Patients were assigned to four groups: CTR = 0; 0 < CTR <0.5; 0.5 ≤ CTR <1 (ground‐glass opacity [GGO] group); and CTR = 1 (pure‐solid group). CD4+, CD8+, and FoxP3+ TIL density and PD‐L1 and IDO1 tumor expression were assessed by immunohistochemistry. Results Among the GGO group, CD8+ and FoxP3+ TIL density increased significantly with increasing CTR (p < 0.001 and p < 0.001, respectively). Moreover, PD‐L1 and IDO1 expression was significantly higher in the pure‐solid group than in the GGO group (p < 0.001 and p < 0.001, respectively). Conclusions CTR was correlated with the abundance of CD8+ and FoxP3+ TILs in the GGO group. PD‐L1 and IDO1 positivity rates were significantly higher in the pure‐solid group than in the GGO group. Increased CTR may be correlated with immunosuppressive condition.

Keywords